Zhang Xiaojia, Chen Deqing, Wang Jiaqi, Liu Jinding, Guo Hualin, Zhang Gengqian
Department of Forensic Biology, School of Forensic Medicine, Shanxi Medical University, Wenhua Street 55#, Jinzhong, 030619, Shanxi, China.
Heart Vessels. 2019 Jun;34(6):1052-1063. doi: 10.1007/s00380-018-01323-8. Epub 2019 Jan 2.
It has been demonstrated that S1P receptors affect heart ischaemia-reperfusion (IR) induced injury. However, whether S1P receptors affect IR-induced cardiac death has not been investigated. The aim of this paper is to demonstrate the role of S1P receptors in IR-induced cardiac death. Healthy adult male Sprague-Dawley rats were assigned to the following groups: non-operation control group, sham operation group, IR group, IR group pretreated with DMSO, IR group pretreated with S1P3 agonist, IR group pretreated with an antagonist of S1P3, IR group pretreated with S1P2 and S1P3 antagonists, IR group pretreated with heptanol and antagonists of S1P2/3, and IR group pretreated with Gap26 and antagonists of S1P2/3 (heptanol acts as a Cx43 uncoupler and the mimic peptide Gap26 as Cx43 blocker). The groups with S1P2 or S1P3 agonist application before reperfusion were used to assess whether these can be used for therapy of IR. The haemodynamics, electrocardiograms (ECG), infarction area, and mortality rates were recorded. Immunohistological connexin 43 (Cx43) expression in the heart was detected in each group. Blocking S1P2/3 receptors with specific antagonists resulted in an increment of IR-induced mortality, increased infarction size, redistribution of Cx43 expression, as well as affecting the heart function. The infarction size, heart function, and mortality were totally or partially restored in the S1P2, S1P3 agonist-pretreated IR group, and the heptanol/Gap26-treated S1P2/3-blocked IR group. The S1P receptor S1P2/3 and Cx43 are involved in the IR-induced cardiac death.
已证实1-磷酸鞘氨醇(S1P)受体影响心脏缺血再灌注(IR)诱导的损伤。然而,S1P受体是否影响IR诱导的心脏死亡尚未得到研究。本文的目的是证明S1P受体在IR诱导的心脏死亡中的作用。将健康成年雄性Sprague-Dawley大鼠分为以下几组:非手术对照组、假手术组、IR组、用二甲基亚砜(DMSO)预处理的IR组、用S1P3激动剂预处理的IR组所用、用S1P3拮抗剂预处理的IR组、用S1P2和S1P3拮抗剂预处理的IR组、用庚醇和S1P2/3拮抗剂预处理的IR组,以及用Gap26和S1P2/3拮抗剂预处理的IR组(庚醇作为一种连接蛋白43(Cx43)解偶联剂,模拟肽Gap26作为Cx43阻滞剂)。在再灌注前应用S1P2或S1P3激动剂的组用于评估这些激动剂是否可用于IR的治疗。记录血流动力学、心电图(ECG)、梗死面积和死亡率。检测每组心脏中免疫组织化学连接蛋白43(Cx43)的表达。用特异性拮抗剂阻断S1P2/3受体会导致IR诱导的死亡率增加、梗死面积增大、Cx43表达重新分布,并影响心脏功能。在S1P2、S1P3激动剂预处理的IR组以及庚醇/Gap26处理的S1P2/3阻断的IR组中,梗死面积、心脏功能和死亡率全部或部分恢复。S1P受体S1P2/3和Cx43参与了IR诱导的心脏死亡。